Gene sequencing machine maker Illumina reiterates full-year guidance

The US company has seen a slowdown in key markets such as China, and has recorded weak demand from customers such as medical research labs and hospitals. Illumina has said that first-quarter revenue was $1.08bn.

Read the full article.